Treatment of Severe Alopecia Areata With Intralesional Steroid Injections
October 2009 | Volume 8 | Issue 10 | Original Article | 909 | Copyright © 2009
Kyung Hee Chang MD PhD, Salinee Rojhirunsakool MD, Lynne J. Goldberg MD
Background: Treatment of alopecia areata with intralesional steroid injection is generally recommended for people who have less
than 50% scalp involvement. In a specialized hair loss clinic, the authors successfully treated patients with extensive alopecia areata
(over 50% but under 99%) with intralesional corticosteroid injections.
Observations: A review of patients with extensive alopecia areata was done. Six out of 10 patients responded to treatment with intralesional triamcinolone acetonide. In comparison to the non-responders, the responders tended to have exclamation mark hairs and a positive hair pull test at their initial physical examination, and exhibited improvement during the initial months of treatment. Complications were negligible, with mild reversible atrophy in three patients. The treatment was well tolerated and, in some patients, pain was minimized by use of a topical anesthetic agent applied under occlusion prior to the visit.
Conclusion: Intralesional triamcinolone acetonide is a safe and effective treatment for patients with extensive alopecia areata. Patients with exclamation point hairs and a positive hair pull test may be more likely to respond.
Purchase Original Article
Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.
Download the original manuscript as it was published in the JDD.
Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.
To get access to JDD's full-text articles and archives, upgrade here.
Save an unformatted copy of this article for on-screen viewing.
Print the full-text of article as it appears on the JDD site.→ proceed | ↑ close